Pharvaris N.V. - Ordinary Shares (NQ:PHVS)

26.27 -0.15 (-0.57%)

Streaming Delayed Price Updated: 12:09 PM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pharvaris N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

September 06, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris To Present at the 2023 HAEi Regional Conference EMEA

August 23, 2023

From Pharvaris N.V.

Via GlobeNewswire

Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday ↗

August 18, 2023

U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

8 Analysts Have This to Say About Pharvaris ↗

August 15, 2023

Via Benzinga

Analyst Expectations for Pharvaris's Future ↗

July 17, 2023

Via Benzinga

Why Shares of Pharvaris N.V. Are Up Tuesday ↗

June 27, 2023

Promising news from the Food and Drug Administration spurred the healthcare stock's rise.

Via The Motley Fool

5 Analysts Have This to Say About Pharvaris ↗

June 26, 2023

Via Benzinga

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Pharvaris ↗

April 06, 2023

Via Benzinga

Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday ↗

August 15, 2023

U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update

August 07, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris Presents Clinical Data at the 2023 U.S. HAEA National Summit

July 21, 2023

From Pharvaris N.V.

Via GlobeNewswire

FDA Removes Clinical Hold Of Pharvaris' Deucrictibant For On-Demand Treatment Of HAE ↗

June 26, 2023

Pharvaris NV (NASDAQ: PHVS) announced that the FDA lifted the clinical hold on the Investigational New Drug (IND) application for deucrictibant (PHA-121) for the on-demand

Via Benzinga

Pharvaris Announces FDA Removal of Clinical Hold of Deucrictibant for the On-Demand Treatment of HAE

June 26, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris Announces $70 Million Private Placement Financing

June 20, 2023

From Pharvaris N.V.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 12, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

Data of Deucrictibant for the On-Demand Treatment of HAE Attacks Presented at the EAACI Congress 2023

June 10, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris Announces Annual Meeting of Shareholders

June 01, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update

May 08, 2023

From Pharvaris N.V.

Via GlobeNewswire

Deucrictibant Data Highlighted in Multiple Presentations at the C1-Inhibitor Deficiency and Angioedema Workshop

May 06, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

April 05, 2023

From Pharvaris N.V.

Via GlobeNewswire

Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC

March 18, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris to Present in Upcoming March Investor Conferences

March 02, 2023

From Pharvaris N.V.

Via GlobeNewswire

Pharvaris to Highlight Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks at AAAAI Annual Meeting

February 24, 2023

From Pharvaris N.V.

Via GlobeNewswire

Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 24, 2023

Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.

Via Benzinga

Pharvaris to Present at SVB Securities Global Biopharma Conference

February 08, 2023

From Pharvaris N.V.

Via GlobeNewswire

Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday ↗

January 23, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday ↗

January 11, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Pharvaris Provides Regulatory, Clinical, and Corporate Updates

January 09, 2023

From Pharvaris N.V.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.